James A Reiffel (James Reiffel)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 18

Top Topics

Atrial Fibrillation

Chronic Obstructive Pulmonary Disease

Coronary Artery Disease

Top Venues

Journal of the American Heart Association

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

Circulation. Arrhythmia and electrophysiology

This page only lists publications with an associated author ORCID identifier.

Publications

James A Reiffel
Atrial Fibrillation: Why Are We Hiding Reality? Circulation 149 (13) (2024)
James A Reiffel
Atrial Fibrillation: Why Are We Hiding Reality? Circulation 149 (13) (2024)
James A Reiffel
Atrial Fibrillation: Why Are We Hiding Reality? Circulation 149 (13) (2024)
James A Reiffel, Carina Blomstrom-Lundqvist, Giuseppe Boriani, Andreas Goette, Peter R Kowey, Josè Luis Merino, Jonathan P Piccini, Sanjeev Saksena, Alan John Camm
Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 25 (6) (2023)
Alessandro Capucci, James A Reiffel
Atrial fibrillation progression: another step in the RACE to full understanding. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
Brian Olshansky, Deepak L Bhatt, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Peter R Kowey, James A Reiffel, Jean Claude Tardif, Christie M Ballantyne, Mina K Chung, null null
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. Journal of the American Heart Association 12 (5) (2023)
Brian Olshansky, Deepak L Bhatt, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Peter R Kowey, James A Reiffel, Jean Claude Tardif, Christie M Ballantyne, Mina K Chung, null null
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. Journal of the American Heart Association (2023)
Brian Olshansky, Deepak L Bhatt, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Peter R Kowey, James A Reiffel, Jean Claude Tardif, Christie M Ballantyne, Mina K Chung, null null
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. Journal of the American Heart Association 12 (5) (2023)
Brian Olshansky, Deepak L Bhatt, Michael Miller, Phillippe Gabriel Steg, Eliot A Brinton, Terry A Jacobson, Steven B Ketchum, Ralph T Doyle, Rebecca A Juliano, Lixia Jiao, Peter R Kowey, James A Reiffel, Jean Claude Tardif, Christie M Ballantyne, Mina K Chung, null null
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-IT. Journal of the American Heart Association 12 (5) (2023)
James A Reiffel, Carina Blomstrom-Lundqvist, Giuseppe Boriani, Andreas Goette, Peter R Kowey, Josè Luis Merino, Jonathan P Piccini, Sanjeev Saksena, Alan John Camm
Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 25 (6) (2023)
Munveer Thind, David S McKindley, James A Reiffel, Gerald V Naccarelli, John Stewart, Peter R Kowey
Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies. Clinical cardiology 45 (1) (2022)
Philip L Mar, Rakesh Gopinathan Nair, Brooke E Gengler, Mina K Chung, Arturo Perez, Jonathan Dukes, Michael D Ezekowitz, Dhanunjaya R Lakkireddy, Gregory Yoke Hong Lip, Mike Miletello, Peter A Noseworthy, James A Reiffel, James E Tisdale, Brian Olshansky, null null
Drug Interactions Affecting Oral Anticoagulant Use. Circulation. Arrhythmia and electrophysiology 15 (6) (2022)
Munveer Thind, Wojciech Zareba, Dan Atar, Harry J G M Crijns, Jun Zhu, Hui Nam Pak, James A Reiffel, Ulf Ludwigs, Mattias Wieloch, John Stewart, Peter R Kowey
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials. Clinical cardiology 45 (1) (2022)
Philip L Mar, Piotr Horbal, Mina K Chung, Jonathan W Dukes, Michael D Ezekowitz, Dhanunjaya R Lakkireddy, Gregory Yoke Hong Lip, Mike Miletello, Peter A Noseworthy, James A Reiffel, James E Tisdale, Brian Olshansky, Rakesh Gopinathan Nair, null null
Drug Interactions Affecting Antiarrhythmic Drug Use. Circulation. Arrhythmia and electrophysiology 15 (5) (2022)
Alan John Camm, Carina Blomstrom-Lundqvist, Giuseppe Boriani, Andreas Goette, Peter R Kowey, Jose L Merino, Jonathan P Piccini, Sanjeev Saksena, James A Reiffel
AIM-AF: A Physician Survey in the United States and Europe. Journal of the American Heart Association 11 (6) (2022)
James A Reiffel
CHA2DS2-VASc is no longer enough. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 24 (7) (2022)
James A Reiffel
When the time in the therapeutic range falls short: out of range values can be of importance. European heart journal. Cardiovascular pharmacotherapy 7 (3) (2022)
James A Reiffel
When two is not better than one: the amalgamation of atrial fibrillation and chronic obstructive pulmonary disease. European heart journal 42 (35) (2021)